Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRD007 (pemirolast) in children with dystrophinopathy
2011-004667-76Phase 2Completed
- Sponsor
- Cardoz
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemirolast in Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), sponsored by Cardoz. Started Oct 2011; status: completed.
02
Drugs
pemirolast
03
Conditions
Duchenne muscular dystrophy (DMD)Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on 2011-004667-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004667-76.